chr19-7199330-G-A
Variant names: 
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_000208.4(INSR):c.653-14693C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.373 in 151,862 control chromosomes in the GnomAD database, including 10,823 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
 Genomes: 𝑓 0.37   (  10823   hom.,  cov: 30) 
Consequence
 INSR
NM_000208.4 intron
NM_000208.4 intron
Scores
 2
Clinical Significance
 Not reported in ClinVar 
Conservation
 PhyloP100:  0.250  
Publications
5 publications found 
Genes affected
 INSR  (HGNC:6091):  (insulin receptor) This gene encodes a member of the receptor tyrosine kinase family of proteins. The encoded preproprotein is proteolytically processed to generate alpha and beta subunits that form a heterotetrameric receptor. Binding of insulin or other ligands to this receptor activates the insulin signaling pathway, which regulates glucose uptake and release, as well as the synthesis and storage of carbohydrates, lipids and protein. Mutations in this gene underlie the inherited severe insulin resistance syndromes including type A insulin resistance syndrome, Donohue syndrome and Rabson-Mendenhall syndrome. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Oct 2015] 
INSR Gene-Disease associations (from GenCC):
- insulin-resistance syndrome type AInheritance: AD, AR Classification: DEFINITIVE, STRONG, SUPPORTIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Genomics England PanelApp, G2P
- Donohue syndromeInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), Genomics England PanelApp, G2P
- hyperinsulinism due to INSR deficiencyInheritance: AD Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Genomics England PanelApp, Ambry Genetics
- Rabson-Mendenhall syndromeInheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Genomics England PanelApp
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.74). 
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.438  is higher than 0.05. 
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt | 
|---|---|---|---|---|---|---|---|---|
| INSR | NM_000208.4 | c.653-14693C>T | intron_variant | Intron 2 of 21 | ENST00000302850.10 | NP_000199.2 | ||
| INSR | NM_001079817.3 | c.653-14693C>T | intron_variant | Intron 2 of 20 | NP_001073285.1 | |||
| INSR | XM_011527988.3 | c.653-14693C>T | intron_variant | Intron 2 of 21 | XP_011526290.2 | |||
| INSR | XM_011527989.4 | c.653-14693C>T | intron_variant | Intron 2 of 20 | XP_011526291.2 | 
Ensembl
Frequencies
GnomAD3 genomes  0.373  AC: 56560AN: 151744Hom.:  10813  Cov.: 30 show subpopulations 
GnomAD3 genomes 
 AF: 
AC: 
56560
AN: 
151744
Hom.: 
Cov.: 
30
Gnomad AFR 
 AF: 
Gnomad AMI 
 AF: 
Gnomad AMR 
 AF: 
Gnomad ASJ 
 AF: 
Gnomad EAS 
 AF: 
Gnomad SAS 
 AF: 
Gnomad FIN 
 AF: 
Gnomad MID 
 AF: 
Gnomad NFE 
 AF: 
Gnomad OTH 
 AF: 
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome  0.373  AC: 56573AN: 151862Hom.:  10823  Cov.: 30 AF XY:  0.375  AC XY: 27837AN XY: 74186 show subpopulations 
GnomAD4 genome 
 AF: 
AC: 
56573
AN: 
151862
Hom.: 
Cov.: 
30
 AF XY: 
AC XY: 
27837
AN XY: 
74186
show subpopulations 
African (AFR) 
 AF: 
AC: 
10952
AN: 
41394
American (AMR) 
 AF: 
AC: 
6258
AN: 
15234
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
1476
AN: 
3468
East Asian (EAS) 
 AF: 
AC: 
2342
AN: 
5172
South Asian (SAS) 
 AF: 
AC: 
1420
AN: 
4820
European-Finnish (FIN) 
 AF: 
AC: 
5245
AN: 
10526
Middle Eastern (MID) 
 AF: 
AC: 
118
AN: 
294
European-Non Finnish (NFE) 
 AF: 
AC: 
27564
AN: 
67940
Other (OTH) 
 AF: 
AC: 
764
AN: 
2104
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.505 
Heterozygous variant carriers
 0 
 1789 
 3577 
 5366 
 7154 
 8943 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
 0 
 544 
 1088 
 1632 
 2176 
 2720 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
Alfa 
 AF: 
Hom.: 
Bravo 
 AF: 
Asia WGS 
 AF: 
AC: 
1136
AN: 
3478
ClinVar
Not reported inComputational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 BayesDel_noAF 
 Benign 
 DANN 
 Benign 
 PhyloP100 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.